SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-119084
Filing Date
2023-11-16
Accepted
2023-11-16 16:01:20
Documents
1
Group Members
JUVENESCENCE US CORP.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2330831d1_sc13da.htm SC 13D/A 52930
  Complete submission text file 0001104659-23-119084.txt   54490
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Subject) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90737 | Film No.: 231414534
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1ST FLOOR, VIKING HOUSE ST PAULS SQUARE, RAMSEY Y8 IM8 1GB
Business Address 1ST FLOOR, VIKING HOUSE ST PAULS SQUARE, RAMSEY Y8 IM8 1GB 441624639396
Juvenescence Ltd (Filed by) CIK: 0001724307 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y8 | Fiscal Year End: 1231
Type: SC 13D/A